Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Low dose finasteride doesn't change lipid profile or metabolic parameters in mice.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Clomiphene citrate improves fertility in men taking finasteride for hair loss.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

A 5-year-old boy grew too much hair after using minoxidil, but it went away after stopping the treatment.

Hair loss improved with treatment and successful transplant.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride improves hair loss in women with hyperandrogenism.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hair loss in women may have causes other than hormones.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.